2m 2m 2m 2m 2m 2m 2m
Belite Bio Sp ADR (BLTE)
NASDAQ
$163.14+$2.07 (+1.29%)
Price as of Aug 21, 2026 7:30 PM EDT- $6.5BMarket Cap
- 150.09%1-Year Change
- BiotechnologyIndustry
Belite Bio Sp ADR (BLTE)
$163.14+$2.07 (+1.29%)
BLTE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $161.06 | ||
Change | -$0.88 (-0.54%) | ||
Open | $163.50 | ||
High | $164.81 | ||
Low | $160.44 | ||
Previous Close | $161.94 | ||
Volume | 111,224 | ||
30-Day Average Volume | 174,166 | ||
1-Week Change | -1.07% | ||
1-Month Change | -0.01% | ||
1-Year Change | 150.09% | ||
3-Year Change | 436.87% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 40.3M | ||
Total Assets | $780.6M | ||
Market Cap | $6.5B | ||
Enterprise Value | $6.1B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue